Literature DB >> 25838224

Anti-toll like receptor 4 (TLR4) therapy diminishes cardiac remodeling regardless of changes in blood pressure in spontaneously hypertensive rats (SHR).

Cinthya Echem1, Gisele Facholi Bomfim2, Graziela Scalianti Ceravolo3, Maria Aparecida Oliveira1, Rosângela Aparecida Santos-Eichler1, Luiz Roberto Bechara1, Mariana Matera Veras4, Paulo Hilário Nascimento Saldiva4, Julio Cesar Ferreira1, Eliana Hiromi Akamine1, Zuleica Bruno Fortes1, Ana Paula Dantas5, Maria Helena Catelli de Carvalho6.   

Abstract

Entities:  

Keywords:  Arterial hypertension; Cardiac fibrosis; Cardiac hypertrophy; Cardiac inflammation; Spontaneously hypertensive rats (SHR); Toll-like receptor 4 (TLR4)

Mesh：

Substances：

Year:  2015        PMID： 25838224     DOI： 10.1016/j.ijcard.2015.03.190

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  10 in total

Review 1.  The Role of Dendritic and Endothelial Cells in Cardiorenal Syndrome.

Authors:  Grazia Maria Virzì; Jun Zhang; Federico Nalesso; Claudio Ronco; Peter A McCullough
Journal:  Cardiorenal Med       Date:  2018-01-22       Impact factor: 2.041

Review 2.  Hypertension: a new treatment for an old disease? Targeting the immune system.

Authors:  Gisele Facholi Bomfim; Stefany Bruno Assis Cau; Alexandre Santos Bruno; Aline Garcia Fedoce; Fernando S Carneiro
Journal:  Br J Pharmacol       Date:  2018-07-31       Impact factor: 8.739

3.  Sex differences in TLR4 expression in SHR do not contribute to sex differences in blood pressure or the renal T cell profile.

Authors:  Kasey M Belanger; Riyaz Mohamed; R Clinton Webb; Jennifer C Sullivan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-02-02       Impact factor: 3.619

4.  Association of Toll-like receptor 4 polymorphism with age-dependent systolic blood pressure increase in patients with coronary artery disease.

Authors:  Adnan Kastrati; Marcus Baumann; Simon Schneider; Werner Koch; Petra Hoppmann; Romy Ubrich; Stephan Kemmner; Eva Steinlechner; Uwe Heemann; Karl-Ludwig Laugwitz
Journal:  Immun Ageing       Date:  2015-05-20       Impact factor: 6.400

5.  Loss of MD1 exacerbates pressure overload-induced left ventricular structural and electrical remodelling.

Authors:  Jianye Peng; Yu Liu; Xiaoju Xiong; Congxin Huang; Yang Mei; Zhiqiang Wang; Yanhong Tang; Jing Ye; Bin Kong; Wanli Liu; Teng Wang; He Huang
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

Review 6.  O-Linked β-N-Acetylglucosamine Modification: Linking Hypertension and the Immune System.

Authors:  Rinaldo Rodrigues Dos Passos Junior; Gisele Facholi Bomfim; Fernanda R Giachini; Rita C Tostes; Victor Vitorino Lima
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

Review 7.  Toll-Like Receptors Represent an Important Link for Sex Differences in Cardiovascular Aging and Diseases.

Authors:  Cinthya Echem; Eliana H Akamine
Journal:  Front Aging       Date:  2021-06-24

8.  TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury.

Authors:  Yide Zhang; Weisheng Peng; Xiang Ao; Houyong Dai; Li Yuan; Xinzhong Huang; Qiaoling Zhou
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

Review 9.  Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension.

Authors:  Natalia Muñoz-Durango; Cristóbal A Fuentes; Andrés E Castillo; Luis Martín González-Gómez; Andrea Vecchiola; Carlos E Fardella; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2016-06-23       Impact factor: 5.923

10.  The Akt pathway mediates the protective effects of myeloid differentiation protein 1 in pathological cardiac remodelling.

Authors:  Jianye Peng; Gaofeng Zeng; Peng Zhong; Guangji Wang; ChangCheng Lei; Guoping Tian; Jingsong Chen; Jianfeng Wu; Caijie Shen
Journal:  ESC Heart Fail       Date:  2021-05-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.